« Previous
Next »
The American Journal of Pathology
Volume 180, Issue 3
, Pages 1159-1169
, March 2012
ALDH1-Bright Epithelial Ovarian Cancer Cells Are Associated with CD44 Expression, Drug Resistance, and Poor Clinical Outcome
To access this article, please choose from the options below
Supported by grants NHRI-EX99-9717NC (H.-C.L.) and NHRI-EX100-9717NC (H.-C.L.) from National Health Research Institutes, Taiwan, and by grants TSGH-C100-010-014-S01 (M.-H.Y.) and TSGH-C100-010-014-S02 (H.-C.L.) from Tri-Service General Hospital, Taiwan.
Supplemental material for this article can be found at http://ajp.amjpathol.org or at doi: 10.1016/j.ajpath.2011.11.015.
PII: S0002-9440(11)01079-0
doi: 10.1016/j.ajpath.2011.11.015
© 2012 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
The American Journal of Pathology
Volume 180, Issue 3
, Pages 1159-1169
, March 2012
